Back to Newsroom

Alder BioPharmaceuticals Added to Russell 3000(R) Index

BOTHELL, Wash., June 27, 2014 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc., (“Alder”) (Nasdaq:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today announced that Alder will be added to the Russell 3000® Index at the close of the market today, Friday, June 27, 2014 when Russell Investments reconstitutes its set of U.S. and global equity indexes.

Click here to read more